Share on StockTwits

Sophiris Bio (NASDAQ:SPHS) Insider Randall E. Woods purchased 1,000 shares of the stock in a transaction dated Wednesday, July 9th. The stock was purchased at an average cost of $2.66 per share, for a total transaction of $2,660.00. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Separately, analysts at Stifel Nicolaus reiterated a “buy” rating on shares of Sophiris Bio in a research note on Wednesday, May 14th. They now have a $7.00 price target on the stock, down previously from $9.00.

Shares of Sophiris Bio (NASDAQ:SPHS) traded down 0.74% during mid-day trading on Wednesday, hitting $2.68. The stock had a trading volume of 35,409 shares. Sophiris Bio has a one year low of $2.10 and a one year high of $14.56. The stock’s 50-day moving average is $2.57 and its 200-day moving average is $3.41. The company’s market cap is $43.3 million.

Sophiris Bio (NASDAQ:SPHS) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($0.52) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.50) by $0.02. On average, analysts predict that Sophiris Bio will post $-1.65 earnings per share for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.